The association of nocturnal serum melatonin levels with major depression in patients with acute multiple sclerosis

Psychiatry Research

Volumn 161, Issue 2, 2008, Pages 253-257

  Akpinar, Zehra ^a   Tokgöz, Serhat ^a   Gökbel, Hakki ^a   Okudan, Nilsel ^a   Uǧuz, Faruk ^a   Yilmaz, Gülsüm ^a  

^a SELCUK UNIVERSITY   (Turkey)

Author keywords

Circadian rhythms; Demyelinating diseases; Depression; Melatonin; Multiple sclerosis

Indexed keywords

MELATONIN;

ACUTE DISEASE; ADULT; ARTICLE; BECK DEPRESSION INVENTORY; BLOOD SAMPLING; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HORMONAL THERAPY; HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; INTERVIEW; MAJOR DEPRESSION; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; RATING SCALE; SCORING SYSTEM;

ACUTE DISEASE; ADULT; CIRCADIAN RHYTHM; COMORBIDITY; DEPRESSIVE DISORDER, MAJOR; DISABILITY EVALUATION; FEMALE; HUMANS; MALE; MELATONIN; MIDDLE AGED; MULTIPLE SCLEROSIS;

EID: 54049091063     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2007.11.022     Document Type: Article

References (25)

1. Arendt J. Melatonin. Clinical Endocrinology 29 (1988) 205-229
2. Arendt J. Pineal gland: basic physiology and clinical implications. In: DeGrood L.J. (Ed). Endocrinology. 3rd. ed. (1995), W.B. Saunders, Philadelphia 433-442
3. Beck-Friis J., von Rosen D., Kjellman B.F., Ljunggren J.G., and Wetterberg L. Melatonin in relation to body measures, sex, age, season and the use of drugs in patients with major affective disorders and healthy subjects. Psychoneuroendocrinology 9 (1984) 261-277
4. Boyce P.M. 6-Sulphatoxy melatonin in melancholia. American Journal of Psychiatry 142 (1985) 125-127
5. Cavallo A., Holt K.G., Hejazi M.S., Richards G.E., and Meyer W.J. Melatonin circadian rhythm in childhood depression. Journal of the American Academy Child and Adolescent Psychiatry 26 3 (1987) 395-399
6. Chokroverty, S., 2000. Sleep Disorders. Neurological Diseases. In: Bradley, W.G., Daroff, R.B., Fenichel, G.M. (Eds.), 3rd ed. Butterworth-Heinemann, pp. 1784-1785.
7. Claustrat B., Brun J., and Chazot G. The basic physiology and pathophysiology of melatonin. Sleep Medicine Reviews 9 (2005) 11-24
8. Crasson M., Kjiri S., Colin A., Kjiri K., L'Hermite-Baleriaux M., Ansseau M., and Legros J.J. Serum melatonin and urinary 6-sulfatoxymelatonin in major depression. Psychoneuroendocrinology 29 (2004) 1-12
9. Fanget F., Claustrat B., Dalery J., Brun J., Terra J.L., Marie-Cardine M., and Guyotat J. Nocturnal plasma melatonin levels in schizophrenic patients. Biological Psychiatry 15 (1989) 499-501
10. Haase C.G., Tinnefeld M., and Faustmann P.M. The influence of immunomodulation on psycho-neuroimmunological functions in benign multiple sclerosis. Neuroimmunomodulation (Basel) 11 (2004) 365-372
11. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale. Neurology 33 (1983) 1444-1452
12. Lewy A.J., Wehr T.A., Goodwin F.K., Newsome D.A., and Rosenthal N.E. Manic-depressive patients may be supersensitive to light. Lancet 1 8216 (1981) 383-384
13. McIntyre I.M., Judd F.K., Norman T.R., and Burrows G.D. Plasma melatonin concentrations in depression. Australian and New Zealand Journal of Psychiatry 20 (1986) 381-383
14. Miles A., and Philbrick D.R. Melatonin and psychiatry. Biological Psychiatry 23 (1988) 405-425
15. Miller J.R. Multiple sclerosis. Demyelinating diseases. In: Rowland L.P. (Ed). Merritt's Neurology. 10th edition (2000), Philadelphia 773-788
16. Nair N.P., Hariharasubramanian N., and Pilapil C. Circadian rhythm of plasma melatonin in endogenous depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry 8 (1984) 715-718
17. Polman C.H., Wolinsky J.S., and Reingold S.C. Multiple sclerosis diagnostic criteria: three years later. Multiple Sclerosis 11 (2005) 5-12
18. Rabe-Jablonska J., and Szymanska A. Diurnal profile of melatonin secretion in the acute phase of major depression and in remission. Medical Science Monitor 7 (2001) 946-952
19. Rubin R.T., Heist E.K., McGeoy S.S., Hanada K., and Lesser I.M. Neuroendocrine aspects of primary endogenous depression. XI. Serum melatonin measures in patients and matched control subjects. Archives of General Psychiatry 49 (1992) 558-567
20. Sandyk R., and Awerbuch G.I. Nocturnal melatonin secretion in suicidal patients with multiple sclerosis. International Journal of Neuroscience 71 (1993) 173-182
21. Sandyk R., and Awerbuch G.I. Nocturnal melatonin secretion in multiple sclerosis patients with affective disorders. International Journal of Neuroscience 68 (1993) 227-240
22. Sekula L.K., Lucke J.F., Heist E.K., Czambel R.K., and Rubin R.T. Neuroendocrine aspects of primary endogenous depression. XV: mathematical modeling of nocturnal melatonin secretion in major depressives and normal controls. Psychiatry Research 24 (1997) 143-153
23. Souêtre E., Salvati E., Belugou J.L., Pringuey D., Candito M., Krebs B., Ardisson J.L., and Darcourt G. Circadian rhythms in depression and recovery: evidence for blunted amplitude as the main chronobiological abnormality. Psychiatry Research 28 (1989) 263-278
24. Vaughan G.M., Pelham R.W., Pang S.F., Loughlin L.L., Wilson K.M., Sandock K.L., Vaughan M.K., Koslow S.H., and Reiter R.J. Nocturnal elevation of plasma melatonin and urinary 5-hydroxyindoleacetic acid in young men: attempts at modification by brief changes in environmental lighting and sleep and by autonomic drugs. Journal of Clinical Endocrinology and Metabolism 42 (1976) 752-764
25. Wetterberg L. Melatonin and corticosteroid response to metyrapone in patients with pituitary disease. Progress in Clinical and Biological Research 92 (1982) 283-292